2013
DOI: 10.1016/j.vaccine.2013.05.004
|View full text |Cite
|
Sign up to set email alerts
|

Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: Immunogenicity and safety?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(25 citation statements)
references
References 18 publications
0
23
0
1
Order By: Relevance
“…It was suggested that the decision to administer the meningococcal C conjugate vaccine should be carefully considered in children with SSNS. Yildiz et al [ 9 ] suggested that patients with SSNS in hepatitis B virus (HBV) endemic regions should receive HBV vaccines because of the risk of HBV infections. They also suggested that HBV vaccines might trigger NS relapses in some pediatric patients with NS [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
“…It was suggested that the decision to administer the meningococcal C conjugate vaccine should be carefully considered in children with SSNS. Yildiz et al [ 9 ] suggested that patients with SSNS in hepatitis B virus (HBV) endemic regions should receive HBV vaccines because of the risk of HBV infections. They also suggested that HBV vaccines might trigger NS relapses in some pediatric patients with NS [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
“…Yildiz and colleagues evaluated the effect of HBV vaccine among children with steroid sensitive nephrotic syndrome and they observed a low response to the HBV vaccination and some relapses due to this vaccination in these cases. Finally, they suggested that the HBV vaccination should only be used in patients on low dose or withdrawal of steroid therapy (33). …”
Section: The Present Situation Several Years After Starting the Sumentioning
confidence: 99%
“…The increased risk for relapse in children with nephrotic syndrome has also been reported for the HB vaccine [41,42]. The relapse rates of 41 children with SSNS were lower pre-vaccination (0.12 ± 0.19 per month) than post-vaccination (0.4 ± 0.12 per month; p = 0.002).…”
Section: Vaccine Safetymentioning
confidence: 55%
“…Inferior immunogenicity for three of the seven serotypes was observed in children who were also taking immunomodulators [39]. Reduced immune responses have also been reported in children with SSNS who received the HB vaccine [42]. In that study, HB seroconversion rates and the number of subjects with a protective titer of 10 mIU/mL or greater for antibody against HBsAg (anti-HBs) were lower among children who were taking steroids and also those who were not taking immunosuppressants; this suggested that SSNS was the major cause of their impaired immune responses.…”
Section: Vaccine Immunogenicitymentioning
confidence: 89%